Drug interactions with smoking (Q28247018)

American Journal of Health-System Pharmacy

Europe PubMed Central

title

Drug interactions with smoking (English)

0 references

author name string

Lisa A Kroon

series ordinal

1

0 references

language of work or name

English

0 references

publication date

15 September 2007

0 references

published in

0 references

volume

64

0 references

issue

18

0 references

page(s)

1917-21

0 references

cites work

Metabolism and disposition kinetics of nicotine

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Drug interactions with tobacco smoking. An update

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

31 March 2020

The changing cigarette

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

The role of nicotine in smoking-related cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Time response of cytochrome P450 1A2 activity on cessation of heavy smoking

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

A pilot study of plasma caffeine concentrations in a US sample of smoker and nonsmoker volunteers

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Plasma clozapine concentration coefficients of variation in a long-term study

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Therapeutic drug monitoring of olanzapine: the combined effect of age, gender, smoking, and comedication

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Atypical antipsychotic dosing: the effect of smoking and caffeine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Effects of the CYP 2D6 genotype and cigarette smoking on the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Interaction between fluvoxamine and cotinine or caffeine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Cigarette abstinence, nicotine gum, and theophylline disposition

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Lack of effect of withdrawal from cigarette smoking on theophylline pharmacokinetics

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Effect of passive smoking on theophylline clearance in children

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

The impact of smoking on inhaled insulin.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Safety concerns and health benefits associated with oral contraception

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Prescribing oral contraceptives for women older than 35 years of age.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Epidemiology of oral contraceptives and cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Estimates of the risk of cardiovascular death attributable to low-dose oral contraceptives in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Low-dose oral contraceptive use and the risk of myocardial infarction.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Oral contraceptives and smoking, current considerations: recommendations of a consensus panel

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Heparin kinetics: variables related to disposition and dosage

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Oral progestogen-only contraceptives and cardiovascular risk: results from the Transnational Study on Oral Contraceptives and the Health of Young Women.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414

Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060414